Search alternatives:
progress decrease » progressive decrease (Expand Search), problems decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
progress decrease » progressive decrease (Expand Search), problems decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
421
-
422
-
423
-
424
-
425
B2 decreases glycolytic intermediates in cells.
Published 2025“…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”
-
426
-
427
-
428
-
429
-
430
-
431
S1 Data -
Published 2024“…AA (OR = 3.016) and CA (OR = 2.130) genotypes were identified as risk factors for stage II. ERCC1 significantly decreased in processing of CWP. The cutoff value of ERCC1 was 5.265 pg/ml, with a sensitivity of 90.0% and specificity of 86.7%. …”
-
432
Change in the genotypes of <i>ATM</i>, <i>ERCC1</i>, and <i>XRCC1</i>.
Published 2024“…AA (OR = 3.016) and CA (OR = 2.130) genotypes were identified as risk factors for stage II. ERCC1 significantly decreased in processing of CWP. The cutoff value of ERCC1 was 5.265 pg/ml, with a sensitivity of 90.0% and specificity of 86.7%. …”
-
433
-
434
Enrichment analysis of genes from the significant MS module.
Published 2025“…<p><b>(a)</b> Venn diagram showing the intersection of DEGs and significant module genes from WGCNA, resulting in 46 key intersection genes. …”
-
435
-
436
-
437
-
438
-
439
-
440